PVLA
Palvella Therapeutics, Inc
NASDAQ: PVLA · HEALTHCARE · BIOTECHNOLOGY
$130.17
+0.54% today
Updated 2026-05-06
Market cap
$1.82B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.70
Dividend yield
—
52W range
$20 – $151
Volume
0.3M
Palvella Therapeutics, Inc (PVLA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.43M | $5.37M | $2.93M | $5.83M | $25.27M | $29.10M | $46.28M | $29.32M | $31.42M | $25.90M | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | -56.8% | -45.3% | +98.9% | +333.5% | +15.1% | +59.0% | -36.6% | +7.1% | -17.6% | -100.0% | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — | $2.37M | $2.78M | — | — | — |
| Gross profit | — | — | — | — | — | — | — | $29.32M | $29.05M | $23.12M | — | — | — |
| Gross margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 100.0% | 92.5% | 89.3% | — | — | — |
| R&D | $9.41M | $5.60M | $7.64M | $19.70M | $21.92M | $40.92M | $54.36M | $44.22M | $64.20M | $50.21M | $8.79M | $8.15M | $22.84M |
| SG&A | — | — | — | — | — | — | — | — | — | $4.16M | $3.08M | $5.94M | $15.76M |
| Operating income | $553826.00 | $-7.20M | $-13.08M | $-22.76M | $-14.59M | $-30.83M | $-27.16M | $-33.92M | $-51.83M | $-43.47M | $-11.87M | $-14.10M | $-38.60M |
| Operating margin | 4.5% | -134.2% | -446.1% | -390.3% | -57.7% | -105.9% | -58.7% | -115.7% | -165.0% | -167.8% | — | — | — |
| EBITDA | $944813.00 | $-6.83M | $-13.55M | $-22.28M | $-16.18M | $-26.50M | $-24.43M | $-34.94M | $-43.37M | $-30.50M | $18.69M | $-13.12M | $-35.90M |
| EBITDA margin | 7.6% | -127.3% | -462.0% | -382.0% | -64.0% | -91.0% | -52.8% | -119.2% | -138.0% | -117.7% | — | — | — |
| EBIT | $560136.00 | $-7.19M | $-13.85M | $-22.64M | $-16.54M | $-27.07M | $-25.47M | $-37.07M | $-45.74M | $-33.28M | $-11.87M | $-14.10M | — |
| Interest expense | $493937.00 | $2.65M | — | — | — | — | — | — | — | — | $0.00 | $4.32M | $5.82M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $66196.00 | $-9.85M | $-14.06M | $-22.80M | $-17.65M | $-26.75M | $-25.47M | $-37.23M | $-45.74M | $-33.28M | $18.69M | $-17.43M | $-41.72M |
| Net income growth (YoY) | — | -14980.1% | -42.7% | -62.2% | +22.6% | -51.6% | +4.8% | -46.2% | -22.9% | +27.2% | +156.2% | -193.3% | -139.3% |
| Profit margin | 0.5% | -183.6% | -479.5% | -391.0% | -69.8% | -91.9% | -55.0% | -127.0% | -145.6% | -128.5% | — | — | — |